Patents by Inventor Martina Wuttke

Martina Wuttke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR INCREASING STORAGE STABILITY OF FUNGAL SPORES
    Publication number: 20220046930
    Abstract: The present invention relates to a method of producing fungal spores with prolonged storage stability or of prolonging the storage stability of fungal spores comprising subjecting fungal spores to a drying procedure to result in a residual moisture content of 12% or less and a composition comprising fungal spores obtained by said method.
    Type: Application
    Filed: September 16, 2019
    Publication date: February 17, 2022
    Applicant: Bayer Cropscience Biologics GMBH
    Inventors: Bernhardt Michael STEINWENDER, Daniel LANVER, Fred NEUMANN, Martina WUTTKE
  • CHEMICAL COMPOUND AND ITS USE
    Publication number: 20120142728
    Abstract: The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis.
    Type: Application
    Filed: February 16, 2012
    Publication date: June 7, 2012
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Hilmar BISCHOFF, Heike GIELEN-HAERTWIG, Volkhart LI, Carsten SCHMECK, Michael THUTEWOHL, Alexandros VAKALOPOULOS, Olaf WEBER, Martina WUTTKE
  • Chemical compound and its use
    Patent number: 8124775
    Abstract: The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: February 28, 2012
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Hilmar Bischoff, Heike Gielen-Haertwig, Volkhart Li, Carsten Schmeck, Michael Thutewohl, Alexandros Vakalopoulos, Olaf Weber, Martina Wuttke
  • Chemical compound and its use
    Patent number: 8039629
    Abstract: The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: October 18, 2011
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Hilmar Bischoff, Heike Gielen-Haertwig, Volkhart Li, Carsten Schmeck, Michael Thutewohl, Alexandros Vakalopoulos, Olaf Weber, Martina Wuttke
  • Substituted [(phenylethanoyl)amino]benzamides
    Patent number: 7776922
    Abstract: The invention relates to substituted [(phenylethanoyl)amino]benzamides and methods for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of inflammatory disorders such as, for example, cutaneous, respiratory tract and cardiovascular disorders such as, for example, arteriosclerosis and coronary heart disease.
    Type: Grant
    Filed: November 17, 2005
    Date of Patent: August 17, 2010
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Ulf Brüggemeier, Petros Gatsios, Mark Meininghaus, Leila Telan, Elisabeth Woltering, Martina Wuttke, Hartmut Beck, Nils Griebenow, Frank Süβmeier, Niels Svenstrup, Axel Kretschmer, Marcus Bauser, Johannes Köbberling, Wahed Moradi, Siegfried Zaiss, Claudia Hirth-Dietrich, Barbara Albrecht
  • Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating Diseases
    Publication number: 20100048641
    Abstract: The present invention relates to the use of A1 and/or dual A1/A2b agonists of the formulae (IA) and (IB) for preparing a medicament for treating dyslipidemia, metabolic syndrome and diabetes and dyslipidemia, metabolic syndrome and diabetes in association with hypertension and cardiovascular disorders.
    Type: Application
    Filed: February 16, 2007
    Publication date: February 25, 2010
    Applicant: BAYER HEALTHCARE AG LAW AND PATENTS,PATENTS AND LICENSING
    Inventors: Peter Nell, Barbara Albrecht-Küpper, Walter Hübsch, Martina Wuttke, Thomas Krahn, Nicole Diedrichs, Hilmar Bischoff
  • Chemical Compound and Its Use
    Publication number: 20080255068
    Abstract: The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis.
    Type: Application
    Filed: December 15, 2005
    Publication date: October 16, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Hilmar Bischoff, Heike Gielen-Haertwig, Volkhart Li, Carsten Schmeck, Michael Thutewohl, Alexandros Vakalopoulos, Olaf Weber, Martina Wuttke
  • Chemical Compound and Its Use
    Publication number: 20080194609
    Abstract: The present application relates to novel tetrahydroquinoline derivatives, to a process for their preparation, to their use on their own or in combination for treating and/or preventing diseases and to their use for preparing medicaments, in particular as inhibitors of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinemias, dyslipidemias, hypertriglyceridemias, hyperlipidemias, hypercholesterolemias and arteriosclerosis.
    Type: Application
    Filed: December 10, 2005
    Publication date: August 14, 2008
    Applicant: Bayer HeathCare AG
    Inventors: Hilmar Bischoff, Heike Gielen-Haertwig, Volkhart Li, Carsten Schmeck, Michael Thutewohl, Martina Wuttke, Alexandros Vakalopoulos, Olaf Weber
  • Substituted [(Phenylethanoyl)Amino]Benzamides
    Publication number: 20080171786
    Abstract: The invention relates to substituted [(phenylethanoyl)amino]benzamides and methods for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of inflammatory disorders such as, for example, cutaneous, respiratory tract and cardiovascular disorders such as, for example, arteriosclerosis and coronary heart disease.
    Type: Application
    Filed: November 17, 2005
    Publication date: July 17, 2008
    Inventors: Ulf Bruggemeier, Petros Gatsios, Mark Meininghaus, Leila Telan, Elisabeth Woltering, Martina Wuttke, Hartmut Beck, Nils Griebenow, Frank Sussmeier, Niels Svenstrup, Axel Kretschmer, Marcus Bauser, Johannes Kobberling, Wahed Moradi, Siegfried Zaiss, Claudia Hirth-Dietrich, Barbara Albrecht
  • 7H-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof
    Publication number: 20060247303
    Abstract: The present invention relates to substituted 7H-dibenzo[b,g][1,5]dioxocin-5-one-derivatives, to processes for their preparation and to their use in medicaments, in particular as inhibitors of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemia, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias and arteriosclerosis.
    Type: Application
    Filed: October 21, 2003
    Publication date: November 2, 2006
    Applicant: BAYER HEALTHCARE AG
    Inventors: Hilmar Bischoff, Frank-Thorsten Hafner, Carsten Schmeck, Joachim Telser, Alexandros Vakalopoulos, Gabriele Wirtz, Marcus Bauser, David Bruckner, Martina Wuttke
  • Indolin phenylsulfonamide derivatives
    Publication number: 20060100230
    Abstract: The invention relates to novel substituted indolin phenylsulfonamide derivatives, to a method for the production thereof and to the use thereof in medicaments, especially as potent PPAR-delta activating compounds for the prophylaxis and/or treatment of cardiovascular diseases, especially dyslipidaemia and coronary heart diseases.
    Type: Application
    Filed: June 30, 2003
    Publication date: May 11, 2006
    Inventors: Hilmar Bischoff, Elke Dittrich-Wengenroth, Martina Wuttke, Heike Heckroth, Wolfgang Thielemann, Michael Woltering, Michael Otteneder